Despite Elanco Animal Health's improved financials, high debt levels and limited growth opportunities make it a cautious investment. See why ELAN stock is a Hold.

The animal health leader generates consistent revenue and earnings as a result. In 2024, Zoetis' revenue grew by 8% year over ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

While there, he held strategy and marketing roles in the company's animal health division, that later became Zoetis with the IPO in 2013. He led global marketing for new products and its US cattle ...

Angothera, which has so far been funded by grants and the company’s founders, is looking to partner with animal-health-focused companies to create specific products. Partners are expected to ...

France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family ...